BRAND(AED)
Germany - WertheimBiotechnology
Focus: BRAND is a publicly traded biotechnology company headquartered in Wertheim, Germany, specializing in liquid handling with a mid-sized workforce of 501–1,000 employees. The company operates across infectious diseases, metabolic diseases, and life sciences, with an early-stage pipeline focused on obesity and HIV prevention.
Profile data last refreshed 5h ago · AI intelligence enriched 4mo ago
Funding Stage
PUBLIC
Employees
501-1000
Open Jobs
0
About BRAND
AI assessmentNot HiringNo open roles listed right now. Follow BRAND to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from BRAND's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
B-slim
ObesityClinical Trials (1)
NCT02595671B-slim, a Multi-source Digital Super Coach for Sustainable Weight Loss
N/AHelp build intelligence for BRAND
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.